Hope Jumps to Harry as February Sale Concludes

NEWMARKET, UK–As is to be expected of a sale of this nature, the next steps in the careers of the day's leading lots will be in a variety of different avenues and countries, from jump racing to Saudi Arabia and merely a switch of stables within Newmarket. Over the two days, buyers from more than 20 nations signed for broodmare prospects and horses in training.

Harry Derham is already off the mark in the early days of his training career and he added a promising new recruit to his burgeoning National Hunt stable in the shape of the day's top lot, Brentford Hope (GB) (Camelot {GB}), who was bought for 90,000gns with agent Ed Bailey. The 6-year-old has been a smart dual-purpose performer for Richard Hughes, for whom he won three times on the Flat, achieving a rating of 102, and he has recently run second three times over hurdles.

“He's a nice, scopey horse and Harry saw him yesterday,” said Bailey of lot 427. “Brentford Hope has been a high-class performer on the Flat and has run well over hurdles so far, bumping into some decent performers and the form is looking good. He should progress over hurdles and he is for sale.”

Kuwaiti-born owner and trainer Abdullah Salman Alsabah, who is now based in Saudi Arabia with his small string, went to 80,000gns to secure the 3-year-old Mohatu (GB) from the consignment of Jamie Railton, who sold the son of Roaring Lion on behalf of Qatar Racing. The colt, previously trained by William Haggas, won twice in January over a mile.

“He's improving and I will own him and train him,” said Alsabah, who has a team of seven horses. “The racing programme is expanding in Saudi and it is thriving. They are leading the races now and doing very well. There are some good opportunities there and that's why we left our country to go to Riyadh.”

Riotous applause greeted the hammer falling in favour of Jon Thompson and his band of merry men who had clearly had a good lunch before deciding to buy Tenjin (GB) (Night Of Thunder {Ire}) for 75,000gns. 

Now three, Tenjin won over six furlongs last October and has subsequently been regularly placed on the all-weather for Marco Botti to earn a rating of 85. He was signed for by Jamie Piggott and will remain in Newmarket to be trained by John Ryan.

One of the horse's new owners, Jon Thompson, said: “He wants bit of time, and he is going to race for a syndicate in association with the new wine bar in the town, Gee Gee's. I think there are about 17 of us involved in this horse now.”

As the curtain fell on the first sale of the year at Tattersalls, Chairman Edmond Mahony said, “The individual highlight of the 2023 Tattersalls February Sale was without doubt the 250,000 guineas BBA Ireland purchase of the very well-bred broodmare Now Or Never, who is the third-highest-priced broodmare ever sold at the Tattersalls February Sale and the highest price at the sale since 2018, but the real feature of the past two days has been the international participation.”

The clearance rate remained strong at 84% but the aggregate dropped by 29% from last year at 4,141,800gns, albeit from 30 fewer horses sold. All told, 298 changed hands at an average of 13,899gns (-22%) and median of 7,000gns (-30%).

He continued, “Diverse overseas demand has always been the hallmark of the Tattersalls February Sale and other Tattersalls sales of this nature and the consignors have confidence that Newmarket's unique appeal consistently produces an unrivalled marketplace. Even the relatively small February Sale consistently attracts an abundance of buyers from all over the world and we have sold horses to more than 20 different countries over the past two days. Widespread participation from throughout Europe has been matched by the customary strong contingent from throughout the Gulf region and buyers from India and North Africa have also made significant contributions to a solid renewal of the annual curtain-raiser at Park Paddocks. While the figures have not matched last year's impressive returns, the turnover was the fourth highest in the sale's history, the clearance rate has again exceeded 80% and the sustained demand for British and Irish bloodstock at all levels of the market has yet again very much been in evidence at the Tattersalls February Sale.”

Action returns to the ring at Park Paddocks in mid-April for the Craven Sale, which kicks off the breeze-up season in Europe.

The post Hope Jumps to Harry as February Sale Concludes appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Statement On HISA’s Anti-Doping Rules From ARCI

The Association of Racing Commissioners International (ARCI) has formally asked the Federal Trade Commission (FTC) to set aside and temporarily not approve proposed anti-doping and medication control rules proposed by the Horseracing Integrity and Safety Authority (HISA) until the constitutionality of the HISA Act is determined by the Courts.

“This has nothing to do with wanting uniform rules or having a central rule-making authority, two things the ARCI supports,” said Ed Martin, ARCI President. “This all has to do with avoiding a situation where an enforcement action is overturned because the authority of the enforcing entity to act is in question. The potential exposure to the entire sport is avoided by leaving the existing state rules and enforcement in place until this gets sorted out.”

The ARCI Board voted unanimously to make a similar request in early December and the FTC shortly thereafter rejected the proposed HISA rules without prejudice citing reasons of the underlying legal uncertainty. With the Fifth Circuit Court's rejection earlier this week of HISA's petition based on changes made recently to the Act, the potential for regulatory chaos remains.

The filing made today reads as follows:

“ARCI requests that the FTC yet again reject the Rules or, at the very least, withhold decision until all legal challenges to the Act are finally adjudicated. As you might know, in addition to the federal court case that led to the Fifth Circuit's ruling, other litigations raising material questions about the legitimacy and constitutionality of the Act remain pending. Moreover, after HISA resubmitted the proposed Rules, the Fifth Circuit denied HISA and the FTC's petition to vacate the court's earlier ruling and for a rehearing, meaning two important things: (1) by mandate of the Fifth Circuit, the preliminary injunction prohibiting HISA enforcement in states within the Fifth Circuit will return to full effect and no longer be stayed; and (2) the Fifth Circuit's decision that the Act is unconstitutional will stand for the time being.

Once again, the FTC is in a unique position to restore some level of regulatory certainty to the horse-racing industry. It should do so by quickly and publicly announcing what it already determined a few weeks ago–that it will not approve HISA's proposed rules at this time. A decision to the contrary would come at too great a cost, as it would lead to regulatory uncertainty, exacerbate existing confusion throughout the horse-racing industry, and seriously compromise public interests.”

Should the FTC approve the HISA rules and penalties were imposed for a violation of those rules, the action could be appealed and potentially overturned and wiped away due to the finding in the Fifth Circuit that HISA is unconstitutional.

Likewise if a racing commission enforces the existing State anti-doping rule and penalties imposed for a violation are appealed using the argument that the federal rule preempts state action the possibility that it can be overturned also exists.

The only way to avoid this Catch-22 is to leave state rules and enforcement in place by delaying final action on the HISA ADMC rules.

The ARCI has not taken a position on the pending litigation, although some member states have and are litigating the constitutionality of the Act. In August, Martin called for HISA to sit down with all litigants and negotiate a way out. That did not happen.

The post Statement On HISA’s Anti-Doping Rules From ARCI appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Big Stars Twinkle As Entries Taken For Dubai World Cup Meeting

Defending G1 Dubai World Cup hero Country Grammer (Tonalist) is one of over 1,600 entries, including 892 individual horses from 21 countries, entered in the $30.5-million Dubai World Cup night card.

The featured event, sponsored by Emirates Airline, attracted 171 entries. Of the 24 Group or Grade 1 winners besides the Zedan Racing-owned and Bob Baffert-trained Country Grammer, is the duo's three-time Grade I winner Taiba (Gun Runner).

Joining them could be a pair of longshot headliners from last year; namely, GI Kentucky Derby champ Rich Strike (Keen Ice) and upset G1 Saudi Cup victor Emblem Road (Quality Road). Japan continues their well-documented rise on the international racing stage, and 2022 G1 Dubai Turf dead-heater Panthalassa (Jpn) (Lord Kanaloa {Jpn}) holds a Dubai World Cup nomination this time.

As for the rest of the card, the G1 Longines Dubai Sheema Classic nominations includes Japanese stars like the 2022 winner Shahryar (Jpn) (Deep Impact {Jpn}), as well as Equinox (Jpn) (Kitasan Black {Jpn}), the highest-rated 3-year-old in the world last year. Standing in their way is Godolphin trainer Charlie Appleby who has entered Rebel's Romance (Ire) (Dubawi {Ire}), winner of the 2022 GI Breeders' Cup Turf.

Speaking of the Dubai Turf, sponsored by DP World, the other half of the dead heat from last year in Lord North (Ire) (Dubawi {Ire}) returns, while newcomer Saffron Beach (Ire) (New Bay {GB}) made the list. They could be facing rookie international shipper and reigning Hong Kong Horse of the Year Golden Sixty (Aus) (Medaglia d'Oro). Meanwhile, the G1 Dubai Golden Shaheen could pit the Steve Asmussen trainee Gunite (Gun Runner) against RRR Racing's local hero Switzerland (Speightstown).

Grass sprinting noms in the G1 Al Quoz Sprint, sponsored by Azizi Developments, are led by the well-travelled Artorius (Aus) (Flying Artie {Aus}) who could make the journey from Down Under. Irish trainer Aidan O'Brien's three wins in the G2 UAE Derby make him a logical frontrunner, especially as he has nominated GI Breeders' Cup Juvenile Turf winner Victoria Road (Ire) (Saxon Warrior {Jpn}).

The G2 Dubai Gold Cup, sponsored by Al Tayer Motors, could signal the return of 2021 winner and G1 Gold Cup hero Subjectivist (GB) (Teofilo {Ire}). While the rundown of entries for the G2 Godolphin Mile, sponsored by Nakheel, is marked by defending champion Bathrat Leon (Jpn) (Kizuna {Jpn}), as well as Japanese challengers like Lauda Sion (Jpn) (Real Impact {Jpn}) and Derma Louvre (Jpn) (Pyro), plus Americans hopefuls like Pioneer Of Medina (Pioneerof the Nile) and White Abarrio (Race Day).

“We are delighted by the strength and depth of entries for this year's Dubai World Cup meeting,” said Stephanie Cooley, International Manager for the Club. “To have horses from more than 20 countries considering the trip shows the meeting's continued global appeal.”

Invitations for the meeting are set to go out during February. Click here, for the full list of the nominations.

 

The post Big Stars Twinkle As Entries Taken For Dubai World Cup Meeting appeared first on TDN | Thoroughbred Daily News | Horse Racing News, Results and Video | Thoroughbred Breeding and Auctions.

Source of original post

Anabolic Steroid Can Help Repair Joint Issues In Horses, But Use With Caution

Many racing fans may have negative associations with the drug stanozolol, or Winstrol as it was known years ago. Stanozolol is an anabolic steroid that largely entered the racing public's consciousness in 2008 when Big Brown trainer Rick Dutrow told a reporter off-handedly that the Kentucky Derby and Preakness winner received the drug monthly, sparking a debate about whether anabolic steroids should be permitted in racehorses.

Medication regulation has changed considerably since 2008, and systemic use of anabolic steroids is significantly reduced as a result of current rules.

But according to a presentation at the recent annual convention of the American Association of Equine Practitioners, it's possible the drug could have a purpose besides improving performance through increased appetite and muscle acquisition.

Dr. Scott McClure, veterinarian at Midwest Equine Surgery and Sports Medicine, presented an overview of the drug's use intra-articularly for certain types of joint conditions.

There have been several academic studies conducted on intra-articular stanozolol use through the years, some of it in vivo and some of it in living horses. It's thought the drug reduces inflammatory processes and stimulates the production of local growth factors that improve joint health.

A 2012 study of 60 horses with lameness that had not responded to other treatments found no adverse reactions and improvement in 39% of cases treated with stanozolol joint injections. Another study examined the use of weekly intra-articular stanozolol use in horses with acute and chronic osteoarthritis. In that one, 15 of 21 horses in the acute arthritis group rated 0/5 on the AAEP lameness scale after 21 days of treatment, while seven of 19 horses with chronic arthritis were at 0/5 after 35 days of treatment.

Support our journalism

If you appreciate our work, you can support us by subscribing to our Patreon stream. Learn more.

McClure said in his anecdotal experience, the drug can be useful in dealing with osteochondral defects in young horses, including subchondral cysts of the media femoral condyle, meniscal injuries, and racehorses with palmar or plantar osteochondral disease.

There are a number of cautions that go along with the drug's use in a joint, however.

First of all, McClure said, while he's had success with stanozolol, he doesn't consider it a magic bullet and its main purpose is not to cover up pain.

“You still need to be aware of what you're doing,” McClure said. “Your objective is healing. This is not a quick fix. Our objective with this is more to decrease inflammation and stimulate healing of the joint.”

The treatment should be used in conjunction with rest and rehabilitation.

It has been successfully paired with hyaluronic acid and antibiotics, but should not be paired with a corticosteroid, as that would likely inhibit the anabolic pathways that make the stanozolol work in the joint.

Secondly, there is no Food and Drug Administration-approved version of equine stanozolol being produced in this country. There are approved manufacturers in Europe, and compounding pharmacies do make the drug here. McClure cautioned that veterinarians need to be sure they're using micronized stanozolol. Micronized suspensions have smaller particle sizes that are less likely to negatively impact the joint's interior.

Veterinarians should be aware that the use of a non-FDA-approved drug may negate the coverage of their malpractice insurance in specific cases, as most policies will not protect the vet from negative outcomes if an unapproved drug has been used. McClure said he doesn't worry too much about this in his practice, and has established relationships with pharmacies he considers reputable for purchasing the drug.

Of course, the obvious complication is the drug's use in performance horses. Stanozolol has been the cause of drug positives in racehorses internationally, and it is banned by the Federation Equestre Internationale, and prohibited by the United States Equestrian Federation. Those cases are thought to have happened due to systemic introduction, not use in a joint.

“There is one publication that shows the five milligrams in the tarsocrural joint will be absorbed in the synovial membrane fairly quickly,” said McClure. “What is found in the systemic circulation comes and goes rapidly and was not detectable at 36 hours. So it is very short-lived.”

So far, research would suggest that if it's confined to the joint, the drug is not likely to circulate throughout the body in blood for very long. However, injection technique or the use of other therapies can change this, as can the particle size of the preparation and overall joint health.

“If you put this in the wrong horse and get a positive test, it's on you,” said McClure. “Do not reach for a bottle of stanozolol because you're out of Depo (Medrol) or triamcinolone. That is not the right move.”

The post Anabolic Steroid Can Help Repair Joint Issues In Horses, But Use With Caution appeared first on Horse Racing News | Paulick Report.

Source of original post

Verified by MonsterInsights